EXELIXIS, INC.
Biological Products, (No Diagnostic Substances) · 1851 HARBOR BAY PARKWAY, ALAMEDA, CA 94502
官方登記資料
0位追蹤者
1994成立於
關於 EXELIXIS, INC.
Exelixis, Inc. is a genomics-based drug discovery company located in Alameda, California, and the producer of Cometriq, a treatment approved by the U.S. Food and Drug Administration (FDA) for medullary thyroid cancer with clinical activity in several other types of metastatic cancer.
Source: Wikipedia
產業Biological Products, (No Diagnostic Substances)
總部1851 HARBOR BAY PARKWAY, ALAMEDA, CA 94502
成立時間1994
法律形式C Corporation
狀態營運中
專利1295 項專利
AGENTS THAT BIND TO NKG2A AND PD-L1 AND USES THEREOFUS20260226161A1 · 2026
NKG2A BINDING AGENTS AND USES THEREOFUS20260226162A1 · 2026
關鍵數據
法律資訊
| 法定名稱 | EXELIXIS, INC. |
|---|---|
| 法律形式 | C Corporation |
| SEC CIK | 939767在 SEC EDGAR 上查看 ↗ |
| EIN | 04-3257395 |
| 產業代碼(SIC) | 2836 |
| 登記地址 | 1851 HARBOR BAY PARKWAY, ALAMEDA, CA 94502 |
| 狀態 | 營運中 |
來源: SEC EDGAR · 更新於 2026年10月15日